PETS(PETS)
PETS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $180M | $184M |
| Low | $180M | $184M |
| High | $180M | $184M |
| EBITDA Avg | $2M | $2M |
| Low | $2M | $2M |
| High | $2M | $2M |
| EBIT Avg | $-3M | $-3M |
| Low | $-3M | $-3M |
| High | $-3M | $-3M |
| Net Income Avg | $1M | $2M |
| Low | $1M | $2M |
| High | $1M | $2M |
| EPS Avg | $0.07 | $0.09 |
| Low | $0.07 | $0.09 |
| High | $0.07 | $0.09 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $62M | $55M | $56M |
| Low | $62M | $55M | $56M |
| High | $62M | $55M | $56M |
| EBITDA Avg | $759,239 | $673,519 | $685,765 |
| Low | $759,239 | $673,519 | $685,765 |
| High | $759,239 | $673,519 | $685,765 |
| EBIT Avg | $-890,270 | $-789,756 | $-804,115 |
| Low | $-890,270 | $-789,756 | $-804,115 |
| High | $-890,270 | $-789,756 | $-804,115 |
| Net Income Avg | $-1M | $-2M | $3M |
| Low | $-1M | $-2M | $3M |
| High | $-1M | $-2M | $3M |
| EPS Avg | $-0.06 | $-0.11 | $0.12 |
| Low | $-0.06 | $-0.11 | $0.12 |
| High | $-0.06 | $-0.11 | $0.12 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |